HB 572 Public Health Opioid Overdose Reversal Drugs

---

About HB-572

Requiring a licensed health care provider, when issuing a standing order for an opioid overdose reversal drug, to allow an individual to choose any formulation of any opioid overdose reversal drug approved by the federal Food and Drug Administration; and prohibiting certain private and public entities that prescribe and dispense opioid overdose reversal drugs from being required to keep in stock and dispense all opioid overdose reversal drugs approved by the federal Food and Drug Administration.